| Miss Megan E Kernan, PT, DPT | |
|
4305 Medical Center Dr, Suite 4305, Fayetteville, NY 13066-6638 | |
| (315) 329-7400 | |
| (315) 329-7403 |
| Full Name | Miss Megan E Kernan |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 4305 Medical Center Dr, Fayetteville, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275841397 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Megan E Kernan, PT, DPT 4305 Medical Center Dr, Suite 4305, Fayetteville, NY 13066-6638 Ph: (315) 329-7400 | Miss Megan E Kernan, PT, DPT 4305 Medical Center Dr, Suite 4305, Fayetteville, NY 13066-6638 Ph: (315) 329-7400 |
News Archive
Researchers at the Bellvitge Institute of Biomedical Research (IDIBELL) led by Cristina Costa from the New Therapies on Genes and Transplantation group have shown that inhibition of one of the basic components of the complement system protects chondrocytes (cartilage cells) from porcine rejection of xenotransplantation (transplantation between animals of different species).
Researchers from UNC Lineberger Comprehensive Cancer Center are part of a team that has identified a protein, called P-Rex1, that is key to the movement of cells called melanoblasts. When these cells experience uncontrolled growth, melanoma develops.
CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China, announced today that the China Food and Drug Administration (CFDA) has approved the Company's application to conduct a Phase 2 global clinical trial in ovarian clear cell carcinoma (OCCC) patients for its proprietary drug candidate ENMD-2076.
Samuel K. Sia, assistant professor of biomedical engineering at Columbia Engineering, has developed an innovative strategy for an integrated microfluidic-based diagnostic device-in effect, a lab-on-a-chip-that can perform complex laboratory assays, and do so with such simplicity that these tests can be carried out in the most remote regions of the world.
Oncologists often have to wait months before they can determine whether a treatment is working.
› Verified 1 days ago
Mr. Louis A. Frechette, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4305 Medical Center Dr, Suite 4305, Fayetteville, NY 13066 Phone: 315-329-7400 Fax: 315-329-7403 | |
Mackenzie Jane Stuck, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 510 Towne Dr, Fayetteville, NY 13066 Phone: 315-637-4747 Fax: 315-637-6711 | |
Janet Lynne Murphy, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 510 Towne Dr, Suite 100, Fayetteville, NY 13066 Phone: 315-637-4747 Fax: 315-637-6711 | |
Ms. Marilyn E Rees, MPS Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 209 Homewood Dr, Fayetteville, NY 13066 Phone: 315-637-0236 | |
Kelly M Zawacki, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 510 Towne Dr, Ste 100, Fayetteville, NY 13066 Phone: 315-637-4747 Fax: 315-637-6711 | |
Mr. George Barrett, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6800 E Genesee St, Suite A, Fayetteville, NY 13066 Phone: 315-478-0380 Fax: 315-478-0388 | |
Patricia Jean Boehlert, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4401 Medical Center Dr Ste 401, Fayetteville, NY 13066 Phone: 315-329-2550 Fax: 315-744-1947 |